Related Experiment Video

Updated: Dec 24, 2025

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

1.2K

Vaccination for Pancreatic Ductal Adenocarcinoma: A Hard Nut to Crack

Diego Salas-Benito1,2, Ignacio Melero2,3,4, Mariano Ponz-Sarvise5,4,6

  • 1Department of Medical Oncology, Clinica Universidad de Navarra, Pamplona, Spain.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|July 19, 2019
PubMed

Insights

Immunotherapy for pancreatic cancer using a novel vaccine combination showed no survival benefit in a recent clinical trial. Further research is needed to improve treatment strategies for pancreatic ductal adenocarcinoma.

Area of Science:

  • Oncology
  • Immunology
  • Vaccine Development

Background:

  • Pancreatic ductal adenocarcinoma (PDAC) remains a challenge for immunotherapy.
  • Current treatment strategies offer limited efficacy.

Purpose of the Study:

  • To evaluate the survival benefit of a combination immunotherapy in patients with pancreatic cancer.

Main Methods:

  • A randomized clinical trial was conducted.
  • Patients received repeated immunization with a Listeria monocytogenes-based vaccine encoding for mesothelin.
  • This was combined with a GM-CSF-transfected allogeneic pancreatic cell vaccine.

Main Results:

  • The combination immunotherapy did not demonstrate a survival benefit for vaccinated patients.
  • No significant improvement in overall survival was observed compared to control groups.

Conclusions:

  • The tested immunotherapy strategy, combining a mesothelin-encoding Listeria vaccine with a GM-CSF pancreatic cell vaccine, failed to improve survival in pancreatic cancer patients.
  • Novel immunotherapy approaches are required for effective treatment of pancreatic ductal adenocarcinoma.

More Related Videos

DIPLOMA Approach for Standardized Pathology Assessment of Distal Pancreatectomy Specimens10:38

DIPLOMA Approach for Standardized Pathology Assessment of Distal Pancreatectomy Specimens

Published on: February 1, 2020

7.8K
Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma06:21

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma

Published on: November 18, 2019

11.9K

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
872
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
229